Also known as Micronase and Diabeta
Glibenclamide (INN), also known as glyburide (USAN), is an antidiabetic drug in a class of medications known as sulfonylureas, closely related to sulfa drugs. It was developed in 1966 in a cooperative study between Boehringer Mannheim (now part of Roche) and Hoechst (now part of Sanofi-Aventis).Source: Wikipedia
Estimated Total Cost: $11.61 for an average of 28 days supply
Patients are most commonly prescribed glyburide to treat diabetes, gestational diabetes, diabetic peripheral neuropathy, and thirst.